Cancers 2014, 6(2), 1020-1030; doi:10.3390/cancers6021020

Molecular Imaging and Therapy of Merkel Cell Carcinoma

1,* email and 1,2
Received: 28 February 2014; in revised form: 8 April 2014 / Accepted: 14 April 2014 / Published: 29 April 2014
(This article belongs to the Special Issue Merkel Cell Carcinoma)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Several molecular imaging modalities have been evaluated in the management of Merkel cell carcinoma (MCC), a rare and aggressive tumor with a high tendency to metastasize. Continuous progress in the field of molecular imaging might improve management in these patients. The authors review the current modalities and their impact on MCC in this brief review article.
Keywords: Merkel cell carcinoma; FDG; PET/CT; fluorodeoxyglucose; molecular; imaging; sentinel node
PDF Full-text Download PDF Full-Text [866 KB, uploaded 29 April 2014 09:57 CEST]

Export to BibTeX |

MDPI and ACS Style

Beylergil, V.; Carrasquillo, J.A. Molecular Imaging and Therapy of Merkel Cell Carcinoma. Cancers 2014, 6, 1020-1030.

AMA Style

Beylergil V, Carrasquillo JA. Molecular Imaging and Therapy of Merkel Cell Carcinoma. Cancers. 2014; 6(2):1020-1030.

Chicago/Turabian Style

Beylergil, Volkan; Carrasquillo, Jorge A. 2014. "Molecular Imaging and Therapy of Merkel Cell Carcinoma." Cancers 6, no. 2: 1020-1030.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert